Novocure
Develops wearable TTFields devices for brain, thoracic and pancreatic tumors.
$17.66
After-hours close−0.17 (−0.95%)
At close$17.83(−0.89%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 91.09%106.07M sharesInsiders 2.61%3.04M sharesOther 6.30%7.34M shares
Shares outstanding 116.45M · Float 95.84M · 82.3% free float
Institutions13F, as of Jun 30, 2026
228 holders · 106.07M shares · 33 new positions · 123 increased · 63 reduced · 40 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 17.37M | 14.92% | +303.9K | Aug 13, 2026 |
| BlackRock, Inc. | 13.41M | 11.52% | +219.9K | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 9.91M | 8.51% | −579.0K | Aug 11, 2026 |
| Vanguard Portfolio Management LLC | 6.27M | 5.39% | +20.8K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.90M | 4.21% | +221.6K | Aug 13, 2026 |
| Morgan Stanley | 4.52M | 3.88% | −19.1K | Aug 13, 2026 |
| State Street Corp | 2.87M | 2.46% | +304.7K | Aug 7, 2026 |
| Geode Capital Management, LLC | 2.80M | 2.40% | +286.6K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 9.10% | 10.49M | 13G | May 8, 2026 ↗ |
| BlackRock, Inc. | 8.30% | 9.08M | 13G | Apr 23, 2025 ↗ |
| Vanguard Portfolio Management | 5.57% | 6.34M | 13G | Apr 28, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Frank X. Leonard | officer: Chief Executive Officer | 461.4K | 0.40% | Jul 1, 2026 |
| Ashley Cordova | officer: Former Chief Executive Officer | 422.6K | 0.36% | Mar 5, 2026 |
| Asaf Danziger | director | 416.7K | 0.36% | Jul 1, 2026 |
| Uri Weinberg | officer: Chf Medical and Innovation Ofr | 267.2K | 0.23% | Mar 5, 2026 |
| Arye Barak Ben | officer: General Counsel | 243.8K | 0.21% | Jul 1, 2026 |
| W. Anthony Vernon | director | 209.3K | 0.18% | Jun 5, 2026 |
| Michal Nath Puri | officer: Chief Human Resources Officer | 203.2K | 0.17% | Jul 1, 2026 |
| William F. Doyle | director, officer: Executive Chairman | 200.0K | 0.17% | Mar 5, 2026 |
| Christoph Brackmann | officer: Chief Financial Officer | 182.8K | 0.16% | Mar 5, 2026 |
| Nicolas Leupin | officer: Former Chief Medical Officer | 103.0K | 0.09% | Mar 5, 2026 |
3 ten-percent owners hold 18.91M shares by Form 4, outside the officers-and-directors figure above · 16 people have not refiled in the last 18 months (8.22M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 4, 2026 | Frank X. Leonardofficer: Chief Executive Officer | Sale | 34,273 | $17.93 | 459,520 |
| Jun 2, 2026 | David Hungdirector | Sale | 2,945 | $15.77 | 20,465 |
| Jun 2, 2026 | W. Anthony Vernondirector | Sale | 2,945 | $15.77 | 197,657 |
| Jun 2, 2026 | Jeryl L. Hillemandirector | Sale | 2,945 | $15.77 | 13,861 |
| Jun 2, 2026 | Timothy J. Scannelldirector | Sale | 2,945 | $15.77 | 14,288 |
| Jun 2, 2026 | Allyson J. Oceandirector | Sale | 2,945 | $15.77 | 11,324 |
| Jun 2, 2026 | Kristin Stafforddirector | Sale | 2,945 | $15.77 | 11,324 |
| Jun 2, 2026 | Gabriel Leungdirector | Sale | 2,945 | $15.77 | 89,499 |
| Mar 3, 2026 | William F. Doyledirector, officer: Executive Chairman | Sale · 2 lots | 71,887 | $12.98 | 328,397 |
| Mar 4, 2026 | Michal Nath Puriofficer: Chief Human Resources Officer | Sale | 1,100 | $13.31 | 201,322 |
CongressHouse and Senate disclosures
Not reported.